RESTEM Reveals Corporate Update And 2026 Strategic Focus
08 Jan 2026 //
GLOBENEWSWIRE
RESTEM To Join 15Th Lifesci Partners Event At J.P. Morgan Conf
18 Dec 2025 //
GLOBENEWSWIRE
Restem Doses First FSHD Patient in Phase 1/2a Restem-L Study
08 Dec 2025 //
GLOBENEWSWIRE
Restem to Host R&D Day Showcasing Next-Gen Immunomodulatory
11 Sep 2025 //
GLOBENEWSWIRE
Restem to Present IIMPACT Trial Design at EULAR 2025 Congress
06 Jun 2025 //
GLOBENEWSWIRE
Restem to Present at the 2025 BIO International Convention
03 Jun 2025 //
GLOBENEWSWIRE
RESTEM Joins Jones Las Vegas Tech & Innovation Conference
01 Apr 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support